as on November 1, 2025 at 1:29 am IST
Day's Low
Day's High

0.19%
Downside
2.94%
Upside

52 Week's Low
52 Week's High

44.04%
Downside
11.61%
Upside

Check Tarsus Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$2.9B
EPS (TTM)
-1.5175
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-7
Industry PE ratio
-0.8126129032258065
PEG Ratio
0EBITDA
-96.4M
Revenue (TTM)
295.5M
Profit Margin
-31.13%
Return On Equity TTM
-31.46%
Track how Tarsus Pharmaceuticals Inc P/E has moved over time to understand its valuation trends.
Tarsus Pharmaceuticals Inc in the last 5 years
Lowest (-38.68x)
September 30, 2021
Today (-7.00x)
October 31, 2025
Industry (-0.81x)
October 31, 2025
Highest (-3.60x)
December 31, 2023
Today’s Price to Earnings Ratio: -7.00x
Compare market cap, revenue, PE, and other key metrics of Tarsus Pharmaceuticals Inc with its industry peers.
| Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | 
|---|---|---|---|---|---|
| BUY | $2.9B | 237.38% | -7 | -31.13% | |
| BUY | $41.1B | 489.62% | -16.34 | -259.82% | |
| BUY | $63.1B | 265.59% | -505.15 | -12.96% | |
| BUY | $107.0B | 101.52% | 29.67 | 31.86% | |
| BUY | $68.6B | 20.33% | 15.65 | 32.13% | 
The Tarsus Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Tarsus Pharmaceuticals Inc investment value today
Current value as on today
₹1,60,328
Returns
₹60,328
(+60.33%)
Returns from Tarsus Pharmaceuticals Inc Stock
₹54,686 (+54.69%)
Dollar Returns*
₹5,642 (+5.64%)
Based on 15 analysts
86.67%
Buy
13.33%
Hold
0.00%
Sell
Based on 15 analysts, 86.67% of analysts recommend a 'BUY' rating for Tarsus Pharmaceuticals Inc. Average target price of $80.38
Get share price movements and forecasts by analysts on Tarsus Pharmaceuticals Inc.
What analysts predicted
14.38%UPSIDE
Target Price
$80.38
Current Price
$68.82
Analyzed by
15 Analysts
Target
$80.38
Tarsus Pharmaceuticals Inc target price $80.38, a slight upside of 14.38% compared to current price of $68.82. According to 15 analysts rating.
Search interest for Tarsus Pharmaceuticals Inc Stock has increased by 45% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:45% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
 POSITIVE IMPACT
POSITIVE IMPACTPrice Rise

In the last 7 days, TARS stock has moved up by 4.4%
 NO EFFECT
NO EFFECTAgainst Peers

In the last 3 years, Insmed Incorporated has given 1021.4% return, outperforming this stock by 747.0%
 NO EFFECT
NO EFFECTAgainst Peers

In the last 1 year, Insmed Incorporated has given 188.7% return, outperforming this stock by 133.7%
| Organisation | Tarsus Pharmaceuticals Inc | 
| Headquarters | 15440 Laguna Canyon Road, Irvine, CA, United States, 92618 | 
| Industry | Health Technology | 
| CEO | Dr. Bobak R. Azamian M.D. | 
| E-voting on shares | Click here to vote | 
| Name | Title | 
|---|---|
| Dr. Bobak R. Azamian M.D. | Co-Founder, President, CEO & Chairman | 
| Mr. Scott Youmans | Vice President of Sales | 
| Ms. Adrienne Kemp | Senior Director of Corporate Communications | 
| Mr. Matthew Rossen M.B.A. | Vice President of Marketing | 
| Mr. Jeffrey S. Farrow CPA | CFO & Chief Strategy Officer | 
| Dr. Seshadri Neervannan Ph.D. | Chief Operating Officer | 
| Mr. Aziz Mottiwala M.B.A. | Chief Commercial Officer | 
| Dr. Elizabeth Yeu M.D. | Chief Medical Officer | 
| Mr. David Nakasone | Head of Investor Relations | 
| Dr. Bryan Wahl J.D., M.D. | General Counsel & Corporate Secretary | 
Tarsus Pharmaceuticals Inc share price today is $68.82 as on at the close of the market. Tarsus Pharmaceuticals Inc share today touched a day high of $70.84 and a low of $68.69.
Tarsus Pharmaceuticals Inc share touched a 52 week high of $76.81 on and a 52 week low of $38.51 on . Tarsus Pharmaceuticals Inc stock price today i.e. is closed at $68.82,which is 10.40% down from its 52 week high and 78.71% up from its 52 week low.
Tarsus Pharmaceuticals Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Tarsus Pharmaceuticals Inc (TARS) shares with as little as ₹88.665 or $1 (as of ) using the INDmoney app. 
      
      For example: If you want to invest $10 or ₹886.65 in Tarsus Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ). 
        Based on Tarsus Pharmaceuticals Inc share’s latest price of $68.82 as on November 1, 2025 at 1:29 am IST, you will get 0.1453 shares of Tarsus Pharmaceuticals Inc. Learn more about
          
            fractional shares .
        
Tarsus Pharmaceuticals Inc stock has given 237.38% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
        
 Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?